Funding Announcements

"We are delighted to welcome our new shareholders,"

"We are delighted to complete this second round with our initial investment partners and bringing in a new investment partner, Infinion. This funding will allow us to extend our work beyond the successfully completed pre-clinical trials where Aurum’s lead product has demonstrated great potential in both stroke treatment and diagnosis. We are especially pleased that Infinion have joined the investment and look forward to them helping to drive Aurum forward with their global expertise in the biopharma sector. There has been few new therapies or diagnostics approved for acute ischaemic stroke in recent years. Our products provide hope for the many patients, carers and healthcare professionals who live with the consequences of this devastating condition."

"Kama is a response to the global mental health epidemic, the sex recession, and the World Association of Sexual Health’s declaration of pleasure as a human right. Our body is the most advanced technology that we will ever interact with and yet we know so little about it, and often leave it to others to make decisions about our health and sexual wellbeing which ultimately leaves us unfulfilled. We provide a solution through our unique, guided, daily practices, built in collaboration with some of the world’s best respected academics and practitioners."

"Edgify allows companies, from any industry, to train complete deep learning and machine learning models, directly on their own edge devices. This mitigates the need for any data transfer to the Cloud and also grants them close to perfect accuracy every time, and without the need to retrain centrally."

"This latest investment shows the belief in the BeneTalk product and team, and helps us move closer to transforming the speech therapy experience for millions of people with our AI-driven speech-tracking technology."